See Full Document Text
29.3.2023 EN Official Journal of the European Union L 91/1
II
(Non-legislative acts)
REGULATIONS
COMMISSION IMPLEMENTING REGULATION (EU) 2023/689
of 20 March 2023
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval
periods of the active substances Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis
subsp. Aizawai strains ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype
H-14) strain AM65-52, Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12
and EG 2348, Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, Cydia pomonella
Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl, malathion, mepanipyrim,
metconazole, metrafenone, pirimicarb, pyridaben, pyrimethanil, rimsulfuron, spinosad, Trichoderma
asperellum (formerly T. harzianum) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly T.
harzianum) strain T11, Trichoderma gamsii (formerly T. viride) strain ICC080, Trichoderma harzianum
strains T-22 and ITEM 908, triclopyr, trinexapac, triticonazole and ziram
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009
concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC
and 91/414/EEC(1), and in particular Article 17, first paragraph, thereof,
Whereas:
(1) Active substances included in Annex I to Directive 91/414/EEC(2) are deemed to have been approved under
Regulation (EC) No 1107/2009 and are listed in Part A of the Annex Commission Implementing Regulation
(EU) No 540/2011(3).
(2) Commission Implementing Regulation (EU) 2022/378(4) extends the approval period of the active substances
Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91,
Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, Bacillus thuringiensis subsp. Kurstaki strains
ABTS 351, PB 54, SA 11, SA12 and EG 2348, Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, Cydia
(1) OJ L 309, 24.11.2009, p. 1.
(2) Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (OJ L 230,
19.8.1991, p. 1).
(3) Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the
European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).
(4) Commission Implementing Regulation (EU) 2022/378 of 4 March 2022 amending Implementing Regulation (EU) No 540/2011 as
regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis (Cohn 1872) strain QST 713,
Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain
AM65-52, Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348, Beauveria bassiana strains
ATCC 74040 and GHA, clodinafop, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl,
malathion, mepanipyrim, metconazole, metrafenone, pirimicarb, Pseudomonas chlororaphis strain MA342, pyrimethanil, Pythium
oligandrum M1, rimsulfuron, spinosad, Trichoderma asperellum (formerly T. harzianum) strains ICC012, T25 and TV1, Trichoderma
atroviride (formerly T. harzianum) strain T11, Trichoderma gamsii (formerly T. viride) strain ICC080, Trichoderma harzianum strains
T-22 and ITEM 908, triclopyr, trinexapac, triticonazole and ziram (OJ L 72, 7.3.2022, p. 2).L 91/2 EN Official Journal of the European Union 29.3.2023
pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl, malathion, mepanipyrim,
metconazole, metrafenone, pirimicarb, pyrimethanil, rimsulfuron, spinosad, Trichoderma asperellum (formerly T.
harzianum) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly T. harzianum) strain T11, Trichoderma
gamsii (formerly T. viride) strain ICC080, Trichoderma harzianum strains T-22 and ITEM 908, triclopyr, trinexapac,
triticonazole and ziram until 30 April 2023.
(3) Commission Implementing Regulation (EU) 2018/1260(5) extends the approval period of the active substance
pyridaben until 30 April 2023.
(4) Applications and supplementary dossiers for the renewal of the approval of those active substances were submitted
in accordance with Commission Implementing Regulation (EU) No 844/2012(6), which continues to apply to these
active substances pursuant to Article 17 of Commission Implementing Regulation (EU) 2020/1740(7), and were
declared admissible by the respective rapporteur Member State.
(5) For the active substances Beauveria bassiana strains ATCC 74040 and GHA, malathion and pyridaben the risk
assessment pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 by the respective rapporteur
Member States has not yet been finalised.
(6) For the active substances Trichoderma asperellum (formerly T. harzianum) strains ICC012, T25 and TV1, Trichoderma
atroviride (formerly T. harzianum) strain T11, Trichoderma gamsii (formerly T. viride) strain ICC080, Trichoderma
harzianum strains T-22 and ITEM 908, the European Food Safety Authority (‘the Authority’) requested additional
information in accordance with Article 13(3) of Implementing Regulation (EU) No 844/2012. It was submitted by
the given deadline of 14 July 2022 and additional time will be needed for its evaluation and for the related
conclusion by risk assessors as well as the ensuing risk management decision in accordance with Articles 13 and 14
of Implementing Regulation (EU) No 844/2012.
(7) For the active substance rimsulfuron, for the purposes of assessment of the approval criteria set out in point 3.6.5
and point 3.8.2 of Annex II to Regulation (EC) No 1107/2009 as amended by Commission Regulation
(EU) 2018/605(8), and in accordance with Article 14(1a) of Implementing Regulation (EU) No 844/2012, EFSA in
consultation with the Member States has to determine if additional information is required. For the active
substances clodinafop and fenpyroximate, the deadline for the submission of additional information for the
purposes of assessment of the approval criteria set out in point 3.6.5 and point 3.8.2 of Annex II to Regulation (EC)
No 1107/2009 as amended by Regulation (EU) 2018/605, and in accordance with Article 13(3a) Implementing
Regulation (EU) No 844/2012 has been set on 17 November 2023 and 4 May 2024 respectively. For the active
(5) Commission Implementing Regulation (EU) 2018/1260 of 20 September 2018 amending Implementing Regulation (EU)
No 540/2011 as regards the extension of the approval periods of the active substances pyridaben, quinmerac and zinc phosphide
(OJ L 238, 21.9.2018, p. 30).
(6) Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the
implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European
Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).
(7) Commission Implementing Regulation (EU) 2020/1740 of 20 November 2020 setting out the provisions necessary for the
implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European
Parliament and of the Council, and repealing Commission Implementing Regulation (EU) No 844/2012 (OJ L 392, 23.11.2020, p. 20).
(8) Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out
scientific criteria for the determination of endocrine disrupting properties (OJ L 101, 20.4.2018, p. 33).29.3.2023 EN Official Journal of the European Union L 91/3
substances cyprodinil, dichlorprop-P, fosetyl, mepanipyrim, metconazole, metrafenone, pirimicarb, pyrimethanil,
spinosad, triclopyr, trinexapac, triticonazole and ziram, additional information for the purposes of assessment of
the approval criteria set out in point 3.6.5 and point 3.8.2 of Annex II to Regulation (EC) No 1107/2009 as
amended by Regulation (EU) 2018/605, was requested by the Authority pursuant Article 13(3a) of Implementing
Regulation (EU) No 844/2012 and was submitted by the applicants within the deadline given. However, additional
time is needed for its evaluation and for the related conclusion by risk assessors as well as the ensuing risk
management decision in accordance with Articles 13 and 14 of Implementing Regulation (EU) No 844/2012.
(8) For the active substances Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis subsp. Aizawai strains
ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, Bacillus
thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348 and Cydia pomonella Granulovirus
(CpGV), the Authority has submitted its conclusion in accordance with Article 13(1) of Implementing Regulation
(EU) No 844/2012 and the Commission has presented the respective renewal reports as well as draft Regulations
renewing the approval of these active substances to the Standing Committee on Plants, Animals, Food and Feed
pursuant to Article 14 of Implementing Regulation (EU) No 844/2012. However, the Standing Committee on
Plants, Animals, Food and Feed has not yet been able to deliver its opinion on any of the draft Regulations renewing
the approvals of the above mentioned active substances.
(9) It is therefore likely that no decision on the renewal of the approval of these active substances can be taken before the
expiry of their respective approvals on 30 April 2023, and the reasons for the delay in the renewal procedures
cannot be attributed to the respective applicants.
(10) Given that the reasons for the delays in the renewal procedures are beyond the control of the respective applicants,
the approval periods of the active substances should be extended in order to enable the completion of the
assessments required and to finalise the regulatory decision-making procedures on the respective applications for
renewal of approval. Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
(11) In case the Commission is to adopt a Regulation providing that the approval of an active substance referred to in the
Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission is to set the
expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation
providing that the approval of the active substance is not renewed, whichever date is later. As regards cases where
the Commission is to adopt a Regulation providing for the renewal of the approval of an active substance referred
to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances,
the earliest possible application date.
(12) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on
Plants, Animals, Food and Feed,
HAS ADOPTED THIS REGULATION:
Article 1
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the
European Union.L 91/4 EN Official Journal of the European Union 29.3.2023
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 20 March 2023.
For the Commission
The President
Ursula VON DER LEYEN29.3.2023 EN Official Journal of the European Union L 91/5
ANNEX
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1) in the sixth column, expiration of approval, of row 74, Ziram, the date is replaced by ‘15 March 2025’;
(2) in the sixth column, expiration of approval, of row 90, Mepanipyrim, the date is replaced by ‘15 March 2025’;
(3) in the sixth column, expiration of approval, of row 123, Clodinafop, the date is replaced ‘15 December 2025’;
(4) in the sixth column, expiration of approval, of row 124, Pirimicarb, the date is replaced by ‘15 March 2025’;
(5) in the sixth column, expiration of approval, of row 125, Rimsulfuron, the date is replaced by ‘15 August 2025’;
(6) in the sixth column, expiration of approval, of row 127, Triticonazole, the date is replaced by ‘15 March 2025’;
(7) in the sixth column, expiration of approval, of row 130, Cyprodinil, the date is replaced by ‘15 March 2025’;
(8) in the sixth column, expiration of approval, of row 131, Fosetyl, the date is replaced by ‘15 March 2025’;
(9) in the sixth column, expiration of approval, of row 132, Trinexapac, the date is replaced by ‘15 December 2024’;
(10) in the sixth column, expiration of approval, of row 133, Dichlorprop-P, the date is replaced by ‘15 March 2025’;
(11) in the sixth column, expiration of approval, of row 134, Metconazole, the date is replaced by ‘15 March 2025’;
(12) in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by ‘15 March 2025’;
(13) in the sixth column, expiration of approval, of row 136, Triclopyr, the date is replaced by ‘15 December 2024’;
(14) in the sixth column, expiration of approval, of row 137, Metrafenone, the date is replaced by ‘15 December 2024’;
(15) in the sixth column, expiration of approval, of row 138, Bacillus subtilis (Cohn 1872) strain QST 713, the date is
replaced by ‘15 August 2024’;
(16) in the sixth column, expiration of approval, of row 139, Spinosad, the date is replaced by ‘15 March 2025’;
(17) in the sixth column, expiration of approval, of row 193, Bacillus thuringiensis subsp. aizawai strain ABTS-1857 and
strain GC-91, the date is replaced by ‘15 August 2024’;
(18) in the sixth column, expiration of approval, of row 194, Bacillus thuringiensis subsp. israeliensis (serotype H-14) strain
AM65-52, the date is replaced by ‘15 August 2024’;
(19) in the sixth column, expiration of approval, of row 195, Bacillus thuringiensis subsp. kurstaki strain ABTS 351, strain
PB 54, strain SA 11, strain SA 12, strain EG 2348, the date is replaced by ‘15 August 2024’;
(20) in the sixth column, expiration of approval, of row 197, Beauveria bassiana strain ATCC 74040, strain GHA, the date is
replaced by ‘30 September 2025’;
(21) in the sixth column, expiration of approval, of row 198, Cydia pomonella Granulovirus (CpGV), the date is replaced by
‘15 August 2024’;
(22) in the sixth column, expiration of approval, of row 204, Trichoderma atroviride (formerly T. harzianum) strain T11, the
date is replaced by ‘15 April 2025’;
(23) in the sixth column, expiration of approval, of row 206, Trichoderma harzianum strain T-22, strain ITEM 908, the date
is replaced by ‘15 April 2025’;
(24) in the sixth column, expiration of approval, of row 207, Trichoderma asperellum (formerly T. harzianum) strain ICC012,
strain T25, strain TV1, the date is replaced by ‘15 April 2025’;L 91/6 EN Official Journal of the European Union 29.3.2023
(25) in the sixth column, expiration of approval, of row 208, Trichoderma gamsii (formerly T. viride) strain ICC080, the date
is replaced by ‘15 April 2025’;
(26) in the sixth column, expiration of approval, of row 213, Fenpyroximate, the date is replaced by ‘15 June 2026’;
(27) in the sixth column, expiration of approval, of row 300, Malathion, the date is replaced by ‘31 July 2026’;
(28) in the sixth column, expiration of approval, of row 313, Pyridaben, the date is replaced by ‘31 July 2026’.